Non-ST Elevated Myocardial Infarction
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Cardiovascular Diseases, Heart Diseases, Myocardial Infarction
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Evolocumab for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inclisiran for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor + placebo for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.